Navigation Links
Pharmaceutical Membrane Filtration Market Worth $7,960.3 Million by 2018 - Report by MarketsandMarkets
Date:7/20/2014

(PRWEB) July 21, 2014

The “Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification, Sterilization, Virus Removal & Water Management), Region (North America, Europe, Asia-Pacific & ROW) - Trends & Forecast to 2018” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.

This report studies the global membrane filtration market for pharmaceutical market over the forecast period of 2013 to 2018. This market is valued at an estimated $3,691.9 million in 2013 and is poised to grow at a CAGR of 16.6% from 2013 to 2018, to reach $7,960.3 million by 2018.

For More Inquiries: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=255408031

Membrane filtration is an important separation technique in the pharmaceutical and biotechnology industries. It finds widespread applications in the biopharmaceutical industry as biopharmaceutical products, and their intermediates are susceptible to degradation due to heat and chemical treatment, which makes it difficult to separate them using alternate technologies. Membrane filtration has been used in pharmaceutical industry since 1935 and is presently one of the most widely adopted separation techniques in these industries. Based on application, the protein purification market holds the largest share in 2013. However, the sterilization market is poised to grow at the highest CAGR from 2013 to 2018.

Request for customization of report @ http://www.marketsandmarkets.com/requestCustomization.asp?id=255408031.

Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries. It finds extensive applications in the biopharmaceutical industry as biopharmaceutical products, and their intermediates are susceptible to degradation due to heat and chemical treatment, and so are difficult to separate using other separation techniques.

Like all other process equipment in the pharmaceutical industry, membrane filtration products approved for use in the pharmaceutical industry have high quality standards. Further, there is a high degree of consolidation in the market, with few large players dominating the market. Stringent regulatory requirements and high degree of consolidation are important entry barriers for new entrants in this market. Small and mid-size players have a small share of the market, and their business interests remain concentrated in local markets across emerging geographies.

The major players in the market are Merck Millipore (U.S.), Pall Corporation (U.S.), and Sartorius Stedim Biotech (France). Other important players in this market are 3M (U.S.) Alfa Laval (Sweden), GE (U.S.), GEA Group (Germany), Graver Technologies (U.S.), Koch Membrane Systems (U.S.), MECO (U.S.), Novasep (France), and Spectrum Laboratories (U.S.).

Browse Related Reports:
Packaging Equipment Market for Pharmaceutical by Product Type (Tablet, Powder, Cream, Syrup, Aseptic Liquid, Aerosol), Package Type (Blister, Strip, Bottle, Tube, Aseptic Packaging, Wrapping, Labeling & Serialization) - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-packaging-equipment-market-19845828.html

Pharmaceutical Excipients Market by Products (Carbohydrates, Oleochemicals, Petrochemicals, Polymers, Microcrystalline Cellulose, Sugar, Calcium carbonate) & by Functionality (Fillers, Binders, Lubricants, Preservatives) – Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology.
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets.

Read the full story at http://www.prweb.com/releases/membrane-filtration/pharmaceutical-market/prweb12018017.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mexico Pharmaceutical Market worth $22.5 Billion with 7% CAGR to 2020 Says a New Report Available at MarketOptimizer.org
2. New UT Arlington research could improve pharmaceuticals testing
3. Aequor Technologies Awarded Managed Services Contract to Provide Hardware Configuration and Deployment for Global Pharmaceutical Corporation
4. NAPW Announces Monica C. Hernandez, Clinical Trial Lead, Otsuka Pharmaceutical Development & Commercialization, VIP Woman of the Year
5. Scientists reduce protein crystal damage, improve pharmaceutical development
6. Nuclear Medicine / Radiopharmaceutical Market is worth $5.55 Billion by 2017 - New Report by MarketsandMarkets
7. Global Pharmaceutical Contract Manufacturing Market
8. Actos Bladder Cancer Allegations Attorney Help: Resource4thePeople Comments on Progress of Federal Litigation Involving Cancer Claims Filed against Takeda Pharmaceuticals
9. Global Pharmaceuticals & Medicine Manufacturing Industry Market Research Report from IBISWorld has Been Updated
10. Database tracks toxic side effects of pharmaceuticals
11. Asia-Pacific Nuclear Medicine/Radiopharmaceutical Market Worth $825 Million By 2017 - New Report by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... "I ... Fla. "I used this old family recipe, which is meant to relieve gout and ... it gave me a 12-hour energy boost every time. It relieved what VA doctors ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy ... in New York, NY, on December 3rd, to benefit Holy Name Medical Center's ... annual event, which raised over $1 million - the largest event in the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital ... and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation ... a few hospitals and facilities have earned this distinction. This is the second ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Fla. , Dec. 9, 2016  Harmar Mobility, LLC announced ... and a member of the Board of Directors. Photo ... ... Mr. Dawson,s ... development of organizations across a variety of industries. He brings to ...
(Date:12/9/2016)... -- Research and Markets has announced the addition of ... offering. ... global travel vaccines market to grow at a CAGR of 6.83% ... scenario and the growth prospects of the global travel vaccines market ... revenue generated from the sales of various vaccines administered to actively ...
(Date:12/8/2016)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced ... stock, $0.01 par value (the "Offering" with such shares being ... terms of the Offering will depend on market and other ... no assurance as to whether or when the Offering may ... proceeds it will receive from this offering for working capital ...
Breaking Medicine Technology: